COLESTID Granule for oral suspension Ref.[9879] Active ingredients: Colestipol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Product name and form

Colestid granules for oral suspension 5 g.

Pharmaceutical Form

Granules for oral suspension.

Light yellow, tasteless and odourless granules.

Qualitative and quantitative composition

Each level scoopful or sachet contains 5 g of colestipol hydrochloride.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Colestipol

Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet.

List of Excipients

Colloidal anhydrous silica

Pack sizes and marketing

Paper/Aluminium foil/vinyl sachets of 5 g (in packs of 10 or 30 sachets).

Pack size: 5 g.

Amber glass bottle with screw cap or HDPE bottle with screw cap or tamper-evident cap.

Pack size: 250 g.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/0950

Date of first authorisation: 26 October 1992
Date of latest renewal: 16 June 2010

Drugs

Drug Countries
COLESTID Canada, Estonia, Spain, Israel, New Zealand, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.